Clinical Predictors and Prognostic Impact of Recovery of Wall Motion Abnormalities in Takotsubo Syndrome: Results From the International Takotsubo Registry
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu srovnávací studie, časopisecké články, multicentrická studie, pozorovací studie, práce podpořená grantem
PubMed
31672100
PubMed Central
PMC6898832
DOI
10.1161/jaha.118.011194
Knihovny.cz E-zdroje
- Klíčová slova
- outcome, recovery, takotsubo syndrome, wall motion abnormalities,
- MeSH
- časové faktory MeSH
- lidé středního věku MeSH
- lidé MeSH
- obnova funkce * MeSH
- prognóza MeSH
- prospektivní studie MeSH
- registrace MeSH
- retrospektivní studie MeSH
- senioři MeSH
- takotsubo kardiomyopatie patofyziologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- Geografické názvy
- Švýcarsko MeSH
Background Left ventricular (LV) recovery in takotsubo syndrome (TTS) occurs over a wide-ranging interval, varying from hours to weeks. We sought to investigate the clinical predictors and prognostic impact of recovery time for TTS patients. Methods and Results TTS patients from the International Takotsubo Registry were included in this study. Cut-off for early LV recovery was determined to be 10 days after the acute event. Multivariable logistic regression was used to assess factors associated with the absence of early recovery. In-hospital outcomes and 1-year mortality were compared for patients with versus without early recovery. We analyzed 406 patients with comprehensive and serial imaging data regarding time to recovery. Of these, 191 (47.0%) had early LV recovery and 215 (53.0%) demonstrated late LV improvement. Patients without early recovery were more often male (12.6% versus 5.2%; P=0.011) and presented more frequently with typical TTS (76.3% versus 67.0%, P=0.040). Cardiac and inflammatory markers were higher in patients without early recovery than in those with early recovery. Patients without early recovery showed unfavorable 1-year outcome compared with patients with early recovery (P=0.003). On multiple logistic regression, male sex, LV ejection fraction <45%, and acute neurologic disorders were associated with the absence of early recovery. Conclusions TTS patients without early LV recovery have different clinical characteristics and less favorable 1-year outcome compared with patients with early recovery. The factors associated with the absence of early recovery included male sex, reduced LV ejection fraction, and acute neurologic events. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT01947621.
1st Department of Cardiology Medical University of Gdansk Poland
Berlin Institute of Health Berlin Germany
Cardiology Royal Brompton and Harefield Hospitals Trust and Imperial College London United Kingdom
Center for Cardiology Cardiology 1 University Medical Center Mainz Mainz Germany
Center for Molecular Cardiology Schlieren Campus University of Zurich Switzerland
Centro Cardiologico Monzino IRCCS Milan Italy
Charles University Prague and University Hospital Kralovske Vinohrady Prague Czech Republic
Clinic for Cardiology and Pneumology Georg August University Goettingen Goettingen Germany
Department of Cardiology and Angiology Hannover Medical School Hannover Germany
Department of Cardiology and Cardiac Imaging Center University Hospital of Rangueil Toulouse France
Department of Cardiology Charité Campus Rudolf Virchow Berlin Germany
Department of Cardiology Christchurch Hospital Christchurch New Zealand
Department of Cardiology Heidelberg University Hospital Heidelberg Germany
Department of Cardiology John Radcliffe Hospital Oxford University Hospitals Oxford United Kingdom
Department of Cardiology Kantonsspital Lucerne Lucerne Switzerland
Department of Cardiology Kantonsspital Winterthur Winterthur Switzerland
Department of Cardiology Kings College Hospital Kings Health Partners London United Kingdom
Department of Cardiology Leiden University Medical Centre Leiden The Netherlands
Department of Cardiology Medical University of Warsaw Poland
Department of Cardiology University Hospital Basel Basel Switzerland
Department of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba Japan
Department of Cardiovascular Sciences Catholic University of the Sacred Heart Rome Rome Italy
Department of General and Interventional Cardiology University Heart Center Hamburg Hamburg Germany
Department of Internal Medicine 1 Cardiology University Hospital Olomouc Olomouc Czech Republic
Department of Internal Medicine 2 Cardiology University of Ulm Medical Center Ulm Germany
Department of Internal Medicine 3 Heart Center University of Cologne Germany
Department of Internal Medicine B University Medicine Greifswald Greifswald Germany
Department of Internal Medicine Cardiology Heart Center Leipzig University Hospital Leipzig Germany
Department of Medicine College of Medicine University of Florida Gainesville FL
Deutsches Herzzentrum München Technische Universität München Munich Germany
Division of Cardiovascular Diseases Mayo Clinic Rochester MN
DZHK Partner Site Berlin Berlin Germany
DZHK Partner Site Greifswald Greifswald Germany
DZHK Partner Site Hamburg Kiel Luebeck Hamburg Germany
DZHK Partner Site Heidelberg Mannheim Mannheim Germany
DZHK Partner Site Munich Heart Alliance Munich Germany
Fondazione Policlinico Universitario A Gemelli IRCCS Roma Italy
Heart and Vascular Centre Bad Bevensen Bad Bevensen Germany
Heart Center Turku University Hospital and University of Turku Turku Finland
Heart Department University Hospital San Giovanni di Dio e Ruggi d'Aragona Salerno Italy
Intensive Coronary Care Unit Moscow City Hospital 1 named after N Pirogov Moscow Russia
Internal Medicine Cardiology Angiology and Pneumology Magdeburg University Magdeburg Germany
Klinik für Innere Medizin 3 Universitätsklinikum des Saarlandes Homburg Saar Germany
Krankenhaus Maria Hilf Medizinische Klinik Stadtlohn Germany
Local Health Unit n 8 Cardiology Unit Arzignano Vicenza Italy
Service de cardiologie Hôpitaux Universitaires de Genève Geneva Switzerland
TJ Health Partners Heart and Vascular Glasgow KY
University Heart Center Department of Cardiology University Hospital Zurich Zurich Switzerland
University Hospital Careggi Florence Italy
University Hospital for Internal Medicine 3 Medical University Innsbruck Innsbruck Austria
University of Southern California Keck School of Medicine Los Angeles CA
Zobrazit více v PubMed
Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, Seifert B, Hellermann J, Schwyzer M, Eisenhardt K, Jenewein J, Franke J, Katus HA, Burgdorf C, Schunkert H, Moeller C, Thiele H, Bauersachs J, Tschope C, Schultheiss HP, Laney CA, Rajan L, Michels G, Pfister R, Ukena C, Bohm M, Erbel R, Cuneo A, Kuck KH, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun‐Dullaeus RC, Cuculi F, Banning A, Fischer TA, Vasankari T, Airaksinen KE, Fijalkowski M, Rynkiewicz A, Pawlak M, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Franz WM, Empen K, Felix SB, Delmas C, Lairez O, Erne P, Bax JJ, Ford I, Ruschitzka F, Prasad A, Luscher TF. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373:929–938. PubMed
Ghadri JR, Cammann VL, Napp LC, Jurisic S, Diekmann J, Bataiosu DR, Seifert B, Jaguszewski M, Sarcon A, Neumann CA, Geyer V, Prasad A, Bax JJ, Ruschitzka F, Luscher TF, Templin C; International Takotsubo (InterTAK) Registry . Differences in the clinical profile and outcomes of typical and atypical takotsubo syndrome: data from the International Takotsubo Registry. JAMA Cardiol. 2016;1:335–340. PubMed
Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, S YH, Migliore F, Horowitz JD, Shimokawa H, Luscher TF, Templin C. International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39:2032–2046. PubMed PMC
Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, S YH, Migliore F, Horowitz JD, Shimokawa H, Luscher TF, Templin C. International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management. Eur Heart J. 2018;39:2047–2062. PubMed PMC
Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, Haas TS, Hodges JS, Maron BJ. Natural history and expansive clinical profile of stress (tako‐tsubo) cardiomyopathy. J Am Coll Cardiol. 2010;55:333–341. PubMed
Schneider B, Athanasiadis A, Schwab J, Pistner W, Gottwald U, Schoeller R, Toepel W, Winter KD, Stellbrink C, Muller‐Honold T, Wegner C, Sechtem U. Complications in the clinical course of tako‐tsubo cardiomyopathy. Int J Cardiol. 2014;176:199–205. PubMed
Schlossbauer SA, Ghadri JR, Scherff F, Templin C. The challenge of Takotsubo syndrome: heterogeneity of clinical features. Swiss Med Wkly. 2017;147:w14490. PubMed
Kato K, Lyon AR, Ghadri JR, Templin C. Takotsubo syndrome: aetiology, presentation and treatment. Heart. 2017;103:1461–1469. PubMed
Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, Munzel T, Knorr M, Heiner S, D'Ascenzo F, Franke J, Sarcon A, Napp LC, Jaguszewski M, Noutsias M, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschope C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun‐Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El‐Battrawy I, Akin I, Borggrefe M, Horowitz J, Kozel M, Tousek P, Widimsky P, Gilyarova E, Shilova A, Gilyarov M, Winchester DE, Ukena C, Bax JJ, Prasad A, Bohm M, Luscher TF, Ruschitzka F, Templin C. Long‐term prognosis of patients with Takotsubo syndrome. J Am Coll Cardiol. 2018;72:874–882. PubMed
Tornvall P, Collste O, Ehrenborg E, Jarnbert‐Petterson H. A case‐control study of risk markers and mortality in takotsubo stress cardiomyopathy. J Am Coll Cardiol. 2016;67:1931–1936. PubMed
Redfors B, Vedad R, Angeras O, Ramunddal T, Petursson P, Haraldsson I, Ali A, Dworeck C, Odenstedt J, Ioaness D, Libungan B, Shao Y, Albertsson P, Stone GW, Omerovic E. Mortality in Takotsubo syndrome is similar to mortality in myocardial infarction—a report from the SWEDEHEART registry. Int J Cardiol. 2015;185:282–289. PubMed
Tsuchihashi K, Ueshima K, Uchida T, Oh‐mura N, Kimura K, Owa M, Yoshiyama M, Miyazaki S, Haze K, Ogawa H, Honda T, Hase M, Kai R, Morii I; Angina Pectoris‐Myocardial Infarction Investigations in Japan . Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris‐Myocardial Infarction Investigations in Japan. J Am Coll Cardiol. 2001;38:11–18. PubMed
Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four‐year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007;50:448–452. PubMed
Kumar S, Mostow N, Grimm RA. Quick resolution of takotsubo cardiomyopathy: a brief review. Echocardiography. 2008;25:1117–1120. PubMed
Ghadri JR, Cammann VL, Templin C. The International Takotsubo Registry: rationale, design, objectives, and first results. Heart Fail Clin. 2016;12:597–603. PubMed
Shiomura R, Nakamura S, Takano H, Kato K, Inui K, Kubota Y, Komiyama H, Murai K, Asai K, Shimizu W. Impact of brain natriuretic peptide, calcium channel blockers, and body mass index on recovery time from left ventricular systolic dysfunction in patients with takotsubo cardiomyopathy. Am J Cardiol. 2015;116:515–519. PubMed
Natelson BH, Suarez RV, Terrence CF, Turizo R. Patients with epilepsy who die suddenly have cardiac disease. Arch Neurol. 1998;55:857–860. PubMed
Yoshida T, Hibino T, Kako N, Murai S, Oguri M, Kato K, Yajima K, Ohte N, Yokoi K, Kimura G. A pathophysiologic study of tako‐tsubo cardiomyopathy with F‐18 fluorodeoxyglucose positron emission tomography. Eur Heart J. 2007;28:2598–2604. PubMed
Schwarz K, Ahearn T, Srinivasan J, Neil CJ, Scally C, Rudd A, Jagpal B, Frenneaux MP, Pislaru C, Horowitz JD, Dawson DK. Alterations in cardiac deformation, timing of contraction and relaxation, and early myocardial fibrosis accompany the apparent recovery of acute stress‐induced (takotsubo) cardiomyopathy: an end to the concept of transience. J Am Soc Echocardiogr. 2017;30:745–755. PubMed
Scally C, Rudd A, Mezincescu A, Wilson H, Srivanasan J, Horgan G, Broadhurst P, Newby DE, Henning A, Dawson DK. Persistent long‐term structural, functional, and metabolic changes after stress‐induced (takotsubo) cardiomyopathy. Circulation. 2018;137:1039–1048. PubMed PMC
Singh K. Tako‐Tsubo syndrome: issue of incomplete recovery and recurrence. Eur J Heart Fail. 2016;18:1408–1410. PubMed
Templin C, Ghadri JR, Napp LC. Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373:2689–2691. PubMed
ClinicalTrials.gov
NCT01947621